Lixisenatide Subcutaneous and Rituximab and hyaluronidase human, recombinant Subcutaneous
Determining the interaction of Lixisenatide Subcutaneous and Rituximab and hyaluronidase human, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Hyaluronidase and rituximab, Rituximab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Rituximab Intravenous
- Lixisenatide Subcutaneous-Riva-Amoxicillin
- Lixisenatide Subcutaneous-Rivaroxaban
- Lixisenatide Subcutaneous-Rivastigmine
- Lixisenatide Subcutaneous-Rivastigmine Capsules
- Lixisenatide Subcutaneous-Rivastigmine Oral Solution
- Rituximab and hyaluronidase human, recombinant Subcutaneous-Lixtraxen Injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-LMD
- Rituximab and hyaluronidase human, recombinant Subcutaneous-LMD Injection
- Rituximab and hyaluronidase human, recombinant Subcutaneous-LMX 4 Topical application
- Rituximab and hyaluronidase human, recombinant Subcutaneous-LMX 5
- Rituximab and hyaluronidase human, recombinant Subcutaneous-LMX 5 Topical application